Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


3rd Serialization and Traceability for Brand Protection

09 May 2013 - 10 May 2013 - Philadelphia, PA, USA



Bookmark and Share


ExL Pharma’s 3rd Life Science Serialization and Traceability For Brand Protection is the premier event providing pharmaceutical & life science companies with comprehensive take-back-to-the-office serialization, traceability and e-pedigree strategies.

While there is a continued lack of federal guidance, it is still imperative to make the business case for your organization for brand protection purposes. If the supply chain partners are buttoned up throughout your drug’s journey to the customer, you are adding significant value to your brand by not allowing counterfeit or rogue drugs to damage your reputation.

The 2013 event will challenge the audience with new perspectives, speakers, formats and topics not often seen on the conference circuit, including:

Preparing pharma for California’s 2014/15 serialization mandate.

Learning from other industries:  How The Auto Industry Embraced and Integrated Serialization & Track & Trace

End to End Traceability doesn’t end with the wholesaler: Perspectives from pharmacies, hospitals and consumers on stage.

Top Reasons to Attend

This event prepares pharma for California's 2014 Serialization Mandate.

This event teaches pharma the business case for serialization and traceability in the most pain free and cost effective way

This event provides multiple perspectives throughout the supply chain- pharmacies, manufacturers and wholesalers.



Further information
Scientific News
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Immunotherapy Reduces Rheumatoid-Linked Cardiovascular Risk
Study shows combination of two extra-low dose anticytokines reduces disease activity and cardiovascular events.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
Sanofi Working on Zika Vaccine with U.S. Army
Sanofi is working in conjunction with the U.S. Army to develop possible Zika vaccine at faster rate following research agreement.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!